Ricerca
Didattica
Soluzioni
Accedi
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Division of Pulmonary and Critical Care Medicine
David B. Shackelford has not added Biography.
If you are David B. Shackelford and would like to personalize this page please email our Author Liaison for assistance.
LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
Cancer cell Feb, 2013 | Pubmed ID: 23352126
Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers.
Cancer research Nov, 2015 | Pubmed ID: 26574479
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.
Cell reports 01, 2017 | Pubmed ID: 28099841
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
Cancer cell May, 2018 | Pubmed ID: 29763624
University of California Los Angeles David Geffen School of Medicine
Milica Momcilovic1,
Sean T. Bailey2,
Jason T. Lee3,
Charles Zamilpa3,
Anthony Jones3,
Gihad Abdelhady1,
James Mansfield4,
Kevin P. Francis5,
David B. Shackelford1
1Division of Pulmonary and Critical Care Medicine, University of California Los Angeles David Geffen School of Medicine,
2, University of North Carolina at Chapel Hill,
3Department of Molecular and Medical Pharmacology, University of California Los Angeles,
4, Andor Technology,
5Division of Orthopaedic Surgery, University of California Los Angeles David Geffen School of Medicine
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
Copyright © 2024 MyJoVE Corporation. Tutti i diritti riservati